cp wire

CP Wire Articles

  • The program brings together many industry heavyweights including: WuXi NextCODE, ARCH Venture Partners, Polaris Partners and Sequoia Capital
  • The Ireland Strategic Investment Fund is... read more
Wed, 11/28/18 - 09:31 am
admin



Biotech Showcase™, one of the largest biotech investor conferences in the world, announced on 11/27/18 this year’s conference agenda which highlights six therapeutic areas that are... read more

Tue, 11/27/18 - 10:37 am
admin
  • Merck, Abbvie and Amgen VC groups participated
  • Rheostat is focused on developing novel treatments for neurodegeneration, cognition and rare diseases


Rheostat... read more

Mon, 11/26/18 - 10:02 am
admin
  • Danon disease has an estimated prevalence of about 15,000-30,000 patients in the U.S. and E.U.
  • ... read more
Mon, 11/26/18 - 09:46 am
admin

Cyclica announced on 11/26/18 a collaboration with Bayer to advance drug discovery programs by gaining insights into the polypharmacological profiles of small... read more

Mon, 11/26/18 - 09:34 am
admin
  • Trial expected to start in 1H2019
  • Improved protocol may allow for additional claims

Following its meeting with the US Food and Drug Administration (FDA) in Washington DC... read more

Sat, 11/24/18 - 11:06 am
admin

Heat Biologics, Inc. ("Heat") (NASDAQ: HTBX), a biopharmaceutical company developing immunotherapies with the goal of activating a patient's immune system against cancer through T-cell activation... read more

Wed, 11/21/18 - 10:24 am
admin


Cellanyx and clinical collaborators today reported results of a prostate cancer clinical study demonstrating the ability of the company’s live tumor cell phenotypic biomarker test to identify... read more

Wed, 11/21/18 - 10:06 am
admin
  • LEO Pharma is committed to$70 million comprised of equity financing and financial R&D support
  • PellePharm and its stockholders could receive up to an additional $690 million... read more
Tue, 11/20/18 - 09:56 am
admin
  • The new PDUFA date is March 19, 2019
  • The FDA has not requested any additional clinical data or any additional information from the Company as part of the extension


... read more

Tue, 11/20/18 - 09:23 am
admin

Inflazome, a pioneering inflammasome company developing small molecule drugs that block harmful inflammation, today announces the successful completion of a Series B financing round of €40 million... read more

Mon, 11/19/18 - 09:19 am
admin
  • Without a successful bone marrow transplant, mortality in patients with severe LAD-I is 60-75% prior to the age of 2
  • The disease occurs in approximately 1 in 1 million births... read more
Mon, 11/19/18 - 08:59 am
admin

Immunicum will initiate a study of ilixadencel in the fourth quarter of 2018. Following completion of the Ib portion of the study, a Phase II study will be conducted using the checkpoint inhibitor... read more

Fri, 11/16/18 - 08:28 am
admin

UCB, a global biopharmaceutical company working in Parkinson’s disease (PD) and other chronic illnesses, and Verint Systems Inc. (Nasdaq: VRNT), announced on 11/15/18 the release of UCB’s PD Coach... read more

Thu, 11/15/18 - 09:18 am
admin

Company recognizes sponsors’ achievements in clinical trial reporting with inaugural Clārus Awards

JERSEY CITY, N.J., Nov. 14, 2018 – TrialScope, the global leader in clinical trial... read more

Wed, 11/14/18 - 01:35 pm
dgrabenstein
  • GBM AGILE is backed by more than 150 collaborators around the world
  • GBM treatment options and patient outcomes have remained largely unchanged over several decades and there is no... read more
Wed, 11/14/18 - 09:36 am
admin
  • Bicycle Therapeutics currently has 5 oncology candidates in development
  • The company also has development projects underway outside of the oncology arena


Bicycle... read more

Wed, 11/14/18 - 09:18 am
admin

Ribometrix, a biotechnology company developing small molecule therapeutics that directly target RNA to treat human diseases, announced on 11/13/18 that it has completed a $30 million Series A... read more

Wed, 11/14/18 - 12:13 am
admin
  • At 52 weeks, the mean decreases in alkaline phosphatase were -47% and -46% in the 5/10 and 10 mg groups
  • After 26 weeks, the median changes in the pruritus visual analog scale (VAS)... read more
Tue, 11/13/18 - 10:02 am
admin
  • Bipolar disorder affects 5.7 million people in the US alone
  • NRX-101 was previously granted fast track status


NeuroRx, announced on 11/13/18 that it has been granted... read more

Tue, 11/13/18 - 09:01 am
admin

Pages



current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.